SCHEMBL6467853

SCHEMBL6467853

COc1ccc(/C=N/c2ncccc2CNC2CCN(C(=O)O)CC2)c(OC)c1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PKM P14618 2/20 0.40
NOS3 P29474 2/20 0.40
NOS1 P29475 2/20 0.40
NOS2 P35228 2/20 0.40
MEN1 O00255 3/20 0.39
KMT2A Q03164 3/20 0.39
GAA P10253 3/20 0.39
NPC1 O15118 2/20 0.39
RAB9A P51151 2/20 0.39
ALDH1A1 P00352 4/20 0.39
MAPT P10636 4/20 0.39
SMN1; SMN2 Q16637 4/20 0.39
KDM4E B2RXH2 3/20 0.39
NFKB1 P19838 1/20 0.39
MAPK1 P28482 1/20 0.39
NFKB2 Q00653 1/20 0.39
RELA Q04206 1/20 0.39
SIGMAR1 Q99720 2/20 0.39
POLB P06746 2/20 0.38
HTT P42858 2/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6467856 1.00 PKM (0.40) PKMNOS3NOS1NOS2MEN1
SCHEMBL1198337 0.79 KDM4C (0.46) PKMMEN1KMT2AGAANPC1
SCHEMBL4733035 0.78 KMT2A (0.54) MEN1KMT2AGAAALDH1A1SMN1; SMN2
SCHEMBL1198634 0.75 KDM4C (0.49) NOS3NOS1NOS2MEN1KMT2A
SCHEMBL5131734 0.74 RAB9A (0.50) PKMMEN1KMT2AGAANPC1
SCHEMBL5131741 0.74 RAB9A (0.50) PKMMEN1KMT2AGAANPC1
SCHEMBL2101049 0.69 EPHX2 (0.49) MEN1KMT2AALDH1A1MAPT
SCHEMBL2100254 0.68 CYP1A2 (0.41) MEN1KMT2AALDH1A1MAPTSMN1; SMN2
SCHEMBL29984145 0.67 CD274 (0.61) MEN1KMT2AMAPTPOLB
SCHEMBL27003454 0.67 KMT2A (0.57) MEN1KMT2AGAAALDH1A1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050256098-A1 CGRP receptor antagonists MERCK SHARP & DOHME LLC 2005-11-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050256098-A1 CGRP receptor antagonists CCKBR, BDKRB1, BDKRB2 PKM 3448/4885NOS3 1441/4885NOS1 2069/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.